March 17, 2026 — Stern Cardiovascular and Atria Health have announced a strategic partnership that will accelerate ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
March 16, 2026 — Cytokinetics has announced four presentations related to Myqorzo (aficamten) at the American College of ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
March 10, 2026 — HeartHero has announced that its Premarket Approval (PMA) application for Elliot, the company’s ...
March 4, 2026 — Inflo Health has launched a comprehensive cardiology suite designed to address care management gaps ...
March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...
March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...
Feb. 27, 2026 — The U.S. Food and Drug Administration (FDA) has approved Abbott’s CardioMEMS Hero device — a pulmonary ...
Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...
The American Society of Radiologic Technologists (ASRT) will host a free Virtual Career Fair on March 17, from 4-7 p.m ...
Feb. 16, 2026 — MemorialCare Heart & Vascular Institute at Orange Coast Medical Center has earned national recognition ...
Feb. 11, 2026 —The American Roentgen Ray Society (ARRS) has announced the following radiologists, as well as their ...
Cardiovascular disease (CVD) is a serious global health burden that encompasses a broad group of diseases that affect ...
Feb. 12, 2026 – CellProthera has acquired the transendocardial catheter originally developed by Celyad Oncology. This ...
March 17, 2026